$60,000 of MAXIMUS INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Higher education policy and regulation."
You can find more data on corporate lobbying on Quiver Quantitative.
MMS Insider Trading Activity
MMS insiders have traded $MMS stock on the open market 9 times in the past 6 months. Of those trades, 7 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MMS stock by insiders over the last 6 months:
- BRUCE CASWELL (CEO & President) purchased 3,500 shares.
- JOHN J HALEY purchased 3,490 shares.
- RAYMOND B RUDDY purchased 3,490 shares.
- MICHELLE F. LINK (Chief of Human Resources) has traded it 2 times. They made 0 purchases and 2 sales, selling 3,571 shares.
- GAYATHRI RAJAN has traded it 2 times. They made 2 purchases, buying 131 shares and 0 sales.
- MICHAEL J. WARREN has traded it 2 times. They made 2 purchases, buying 29 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MMS Hedge Fund Activity
We have seen 187 institutional investors add shares of MMS stock to their portfolio, and 150 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VICTORY CAPITAL MANAGEMENT INC removed 2,187,120 shares (-70.3%) from their portfolio in Q3 2024
- BLACKROCK, INC. added 1,007,698 shares (+13.3%) to their portfolio in Q3 2024
- THRIVENT FINANCIAL FOR LUTHERANS removed 774,647 shares (-97.5%) from their portfolio in Q3 2024
- ASSENAGON ASSET MANAGEMENT S.A. added 645,760 shares (+277.0%) to their portfolio in Q3 2024
- GOLDMAN SACHS GROUP INC added 456,786 shares (+298.5%) to their portfolio in Q3 2024
- FMR LLC removed 294,302 shares (-3.2%) from their portfolio in Q3 2024
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 278,900 shares (-86.3%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
